glp 1 agonist or antagonist America's Poison Centers Upcoming wave of hormone-based therapies
Description
Pi-Sunyer et al
Aging Population in Europe: Europe's population is increasingly aging, contributing to an increased incidence of type 2 diabetes and related illnesses
[DOI] [PubMed] [Google Scholar] 59.Hosaka T., et al
Mechanistically, GLP1R is expressed at low levels in the heart and vasculature, raising the possibility that GLP1 might have both direct and indirect actions on the cardiovascular system
Anti-inflammatory and Antifibrotic Effects Chronic inflammation and myocardial fibrosis are hallmarks of HF progression
Inagaki, Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations, J
